Wealthspire Advisors, LLC Biomarin Pharmaceutical Inc Transaction History

Wealthspire Advisors, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 14, 2020	SELL	$79.55 - $124.22 $800,909 - $1.25 Million	-10,068 Closed	0 $0
Q1 2020 May 12, 2020	BUY	$71.37 - $96.85 $718,553 - $975,085	10,068 New	10,068 $851,000
Q1 2019 May 08, 2019	SELL	$84.2 - $98.62 $1,684 - $1,972	-20 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$80.14 - $106.07 $1,602 - $2,121	20 New	20 $2,000

637

177M

2.01M

1.28M

Ticker BMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,824,000
Market Cap $12.2B
Description
BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...

Get notified when there are updates to the investment portfolio of Wealthspire Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Wealthspire Advisors, LLC with notifications on news.